NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81 | -24.3% | 4,210 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $107 | -40.2% | 4,210 | -14.9% | 0.00% | -50.0% |
| Q1 2023 | $179 | -19.0% | 4,947 | -11.4% | 0.00% | 0.0% |
| Q4 2022 | $221 | -99.9% | 5,584 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $260,000 | +7.9% | 5,584 | +1.6% | 0.00% | +50.0% |
| Q2 2022 | $241,000 | -41.2% | 5,497 | -3.0% | 0.00% | -33.3% |
| Q1 2022 | $410,000 | -58.5% | 5,665 | -53.5% | 0.00% | -25.0% |
| Q4 2021 | $988,000 | +38.0% | 12,180 | +97.9% | 0.00% | -33.3% |
| Q3 2021 | $716,000 | -33.9% | 6,155 | -5.8% | 0.01% | -33.3% |
| Q2 2021 | $1,083,000 | +60.4% | 6,534 | +35.0% | 0.01% | -64.0% |
| Q1 2021 | $675,000 | -26.6% | 4,841 | -8.9% | 0.02% | -28.6% |
| Q4 2020 | $920,000 | +26.5% | 5,314 | +1.8% | 0.04% | +9.4% |
| Q3 2020 | $727,000 | +13.2% | 5,222 | -2.8% | 0.03% | +6.7% |
| Q2 2020 | $642,000 | +21.1% | 5,375 | +1.3% | 0.03% | +130.8% |
| Q1 2020 | $530,000 | -17.4% | 5,305 | -2.9% | 0.01% | +8.3% |
| Q4 2019 | $642,000 | +43.0% | 5,463 | +4.6% | 0.01% | +33.3% |
| Q3 2019 | $449,000 | +30.9% | 5,222 | -1.4% | 0.01% | +12.5% |
| Q2 2019 | $343,000 | +24.7% | 5,295 | +20.4% | 0.01% | +14.3% |
| Q1 2019 | $275,000 | -22.3% | 4,398 | -0.9% | 0.01% | -22.2% |
| Q2 2018 | $354,000 | +9.3% | 4,438 | +18.6% | 0.01% | 0.0% |
| Q1 2018 | $324,000 | +24.6% | 3,743 | -0.4% | 0.01% | +28.6% |
| Q4 2017 | $260,000 | -19.0% | 3,759 | +6.5% | 0.01% | -30.0% |
| Q3 2017 | $321,000 | +21.6% | 3,531 | -0.5% | 0.01% | +11.1% |
| Q2 2017 | $264,000 | -4.3% | 3,547 | +20.5% | 0.01% | -35.7% |
| Q1 2017 | $276,000 | +29.0% | 2,944 | -0.1% | 0.01% | +40.0% |
| Q4 2016 | $214,000 | -19.2% | 2,947 | +16.0% | 0.01% | -33.3% |
| Q3 2016 | $265,000 | +7.3% | 2,541 | +0.1% | 0.02% | +7.1% |
| Q2 2016 | $247,000 | – | 2,538 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |